Archana Sidagouda Patil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Archana Sidagouda Patil has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Rajashree Masareddy
Department of Pharmaceutics, KLE College of Pharmacy Belagavi, KLE Academy of Higher Education and Research, Belagavi, India
9 shared publications - Anand Panchakshari Gadad
Department of Pharmaceutics, KLE College of Pharmacy Belagavi, KLE Academy of Higher Education and Research Belagavi, Karnataka, India
5 shared publications Sheetal Patil
Department of Pharmaceutics, KLE College of Pharmacy, KLE Academy of Higher Education and Research
5 shared publicationsYadishma Gaude
Department of Pharmaceutics, KLE College of Pharmacy, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India
5 shared publicationsKrutuja Chougule
Department of Pharmaceutics, KLE College of Pharmacy, KLE Academy of Higher Education and Research
4 shared publicationsRajashree S. Masareddy
Department of Pharmaceutics, KLE College of Pharmacy, KLE Academy of Higher Education and Research Belagavi, Karnataka, India
4 shared publications
Latest Publications
- 3 October 2026
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 19 (10) , 4736-4740
Development and Validation of a UV-Spectrophotometric Method for the Quantification of Cabotegravir
The objective of the present study was to develop and evaluate a simple and reliable UV-spectrophotometric method for the quantification of Cabotegravir, an antiretroviral drug. Cabotegravir exhibited maximum absorbance at 257 nm using methanol as the solvent, with a linear concentration range of 2–12 µg/ml. The proposed method was optimized and validated in accordance with ICH guidelines for parameters including linearity and range, robustness, specificity, sensitivity, ruggedness, and precision, with all results meeting the acceptance criteria. The method demonstrated excellent specificity, selectivity, linearity, precision, robustness, and repeatability, with percent RSD values below 2%. This novel analytical approach is straightforward, reproducible, and reliable, making it suitable for routine quality control analysis of pure Cabotegravir and its pharmaceutical formulations in the industry.
- 3 October 2026
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 19 (10) , 4736-4740
Development and Validation of a UV-Spectrophotometric Method for the Quantification of Cabotegravir
The objective of the present study was to develop and evaluate a simple and reliable UV-spectrophotometric method for the quantification of Cabotegravir, an antiretroviral drug. Cabotegravir exhibited maximum absorbance at 257 nm using methanol as the solvent, with a linear concentration range of 2–12 µg/ml. The proposed method was optimized and validated in accordance with ICH guidelines for parameters including linearity and range, robustness, specificity, sensitivity, ruggedness, and precision, with all results meeting the acceptance criteria. The method demonstrated excellent specificity, selectivity, linearity, precision, robustness, and repeatability, with percent RSD values below 2%. This novel analytical approach is straightforward, reproducible, and reliable, making it suitable for routine quality control analysis of pure Cabotegravir and its pharmaceutical formulations in the industry.
- 27 September 2026
- Published by Taylor & Francis in Natural Product Research
- p. 1-8
Phytochemical characterization and bioactivity of Symplocos racemosa bark against psoriatic inflammation: in silico and In vitro insights
1. Psoriasis represents a persistent inflammatory dermatosis underpinned by immune system dysregulation, characterised by intricate interactions between aberrant immunological signalling networks a...
- 27 September 2026
- Published by Taylor & Francis in Natural Product Research
- p. 1-8
Phytochemical characterization and bioactivity of Symplocos racemosa bark against psoriatic inflammation: in silico and In vitro insights
1. Psoriasis represents a persistent inflammatory dermatosis underpinned by immune system dysregulation, characterised by intricate interactions between aberrant immunological signalling networks a...
- Open Access
- 28 August 2026
- Published by Elsevier in Results in Chemistry
- Vol. 30
Sustainable UV spectrophotometric profiling of quercetin and Daidzein in Nanocubosomes using an EVG-integrated framework
- 28 August 2026
- Published by Elsevier in Results in Chemistry
- Vol. 30
Open AccessSustainable UV spectrophotometric profiling of quercetin and Daidzein in Nanocubosomes using an EVG-integrated framework
- Open Access
- 18 August 2026
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 16 (4) , 1231-1243
Toward Application of Microsponges for Topical Drug Delivery: A Review
The sunscreen industry is a growing industry because of the increasing need for skin protection and increased awareness of the harmful effects of sunlight by the consumer. Day by day more effective sunscreen actives, novel cosmetics are added to the formulator’s repertoire. Microsponges hold a bright future due to their wide pharmaceutical application and unique property like high loading efficiency, small size, better target delivery and controlled release. Sunscreen should be long-lasting to reduce frequency of application and also should have less side effects; microsponges drug delivery helps reach reaching the goal of controlled and site-specific drug delivery. Microsponges enhance the safety and efficacy of Active Pharmaceutical Ingredients (APIs) in sunscreens, cosmetics, and various over-the-counter skin preparations by minimizing side effects. This article includes the methods, evaluation, application, advantages, limitations and recent advancements in microsponges with respect to sunscreens. This study conducted a comprehensive review of all available information on Microsponges; it presents promising new therapeutic drug delivery with respect to sunscreens. Sunscreen agents are mostly unstable, hence microsponges help to extend product stability. According to review, patent activity signifies continued interest, suggesting significant potential for enhancing patient care.
- 18 August 2026
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 16 (4) , 1231-1243
Open AccessToward Application of Microsponges for Topical Drug Delivery: A Review
The sunscreen industry is a growing industry because of the increasing need for skin protection and increased awareness of the harmful effects of sunlight by the consumer. Day by day more effective sunscreen actives, novel cosmetics are added to the formulator’s repertoire. Microsponges hold a bright future due to their wide pharmaceutical application and unique property like high loading efficiency, small size, better target delivery and controlled release. Sunscreen should be long-lasting to reduce frequency of application and also should have less side effects; microsponges drug delivery helps reach reaching the goal of controlled and site-specific drug delivery. Microsponges enhance the safety and efficacy of Active Pharmaceutical Ingredients (APIs) in sunscreens, cosmetics, and various over-the-counter skin preparations by minimizing side effects. This article includes the methods, evaluation, application, advantages, limitations and recent advancements in microsponges with respect to sunscreens. This study conducted a comprehensive review of all available information on Microsponges; it presents promising new therapeutic drug delivery with respect to sunscreens. Sunscreen agents are mostly unstable, hence microsponges help to extend product stability. According to review, patent activity signifies continued interest, suggesting significant potential for enhancing patient care.
- 7 August 2026
- Published by Taylor & Francis in Spectroscopy Letters
- p. 1-24
Development and validation of a UV spectrophotometric method for baicalin quantification in QbD-assisted Symplocos racemosa extract and nano-transferosomal gel: greenness and whiteness assessment
Medicinal plants continue to serve as indispensable reservoirs of bioactive molecules, offering both therapeutic potential and structural diversity for pharmaceutical development.[1] Among these, S...
- 7 August 2026
- Published by Taylor & Francis in Spectroscopy Letters
- p. 1-24
Development and validation of a UV spectrophotometric method for baicalin quantification in QbD-assisted Symplocos racemosa extract and nano-transferosomal gel: greenness and whiteness assessment
Medicinal plants continue to serve as indispensable reservoirs of bioactive molecules, offering both therapeutic potential and structural diversity for pharmaceutical development.[1] Among these, S...
- Open Access
- 28 July 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 10
Graphene quantum dots: A nanotherapeutic frontier in multimodal cancer theranostics and targeted imaging
- 28 July 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 10
Open AccessGraphene quantum dots: A nanotherapeutic frontier in multimodal cancer theranostics and targeted imaging
- 25 July 2026
- Published by Taylor & Francis in Natural Product Research
- p. 1-10
UPLC-MS/mS-based metabolite profiling and wound healing mechanisms of Careya arborea roxb. Explored through in silico and in vivo approaches
1. Burn injuries represent a significant global health concern, accounting for approximately 180,000 deaths annually. Although chemical burns constitute only about 3% of total burn cases, they are ...
- 25 July 2026
- Published by Taylor & Francis in Natural Product Research
- p. 1-10
UPLC-MS/mS-based metabolite profiling and wound healing mechanisms of Careya arborea roxb. Explored through in silico and in vivo approaches
1. Burn injuries represent a significant global health concern, accounting for approximately 180,000 deaths annually. Although chemical burns constitute only about 3% of total burn cases, they are ...
- 1 July 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 22 (1)
Development and Optimization of Lasmiditan-Loaded Nanostructured Lipid Carriers for Enhanced Oral Bioavailability
- 1 July 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 22 (1)
Development and Optimization of Lasmiditan-Loaded Nanostructured Lipid Carriers for Enhanced Oral Bioavailability